Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJLEN.L Regulatory News (JLEN)

  • There is currently no data for JLEN

Acquisition

13 Dec 2019 07:00

RNS Number : 7911W
Jlen Environmental Assets Grp
13 December 2019
 

13 December 2019

 

JLEN Environmental Assets Group Limited

("JLEN" or the "Company")

 

Acquisition of an anaerobic digestion plant and associated waste collection business

 

JLEN, the listed environmental infrastructure fund, is pleased to announce the acquisition of a 70% equity stake in Bio Collectors Holdings Limited ("BCH"). BCH, through its subsidiary companies holds the rights and operational assets that make up the anaerobic digestion ("AD") plant and the Bio Collectors waste collections business.

 

The consideration is made up of an initial upfront payment, including working capital, and additional deferred amounts that are subject to certain conditions being met.

 

The group of companies is based in Merton, London. The AD plant was commissioned in December 2013 and has subsequently been expanded through several phases. The plant has a current thermal capacity of c.10MWth, a waste processing capacity of up to 100,000tpa and predominantly produces biomethane to be injected to the national gas grid. In addition, the plant has 1.7MWe of capacity through two CHP engines and is accredited under the Renewable Heat Incentive (RHI) and Feed-in-Tariff (FiT) schemes. The Bio Collectors waste collections business collects source-separated and packaged food waste for the AD plant from a variety of commercial, industrial and local authorities located in and around Greater London utilising an increasing biogas-powered fleet.

 

The 70% stake in BCH has been acquired from private individuals, with the residual 30% retained by the existing owner who will remain active in the business going forward.

 

This acquisition represents JLEN's first acquisition into food waste fuelled anaerobic digestion, further diversifying the Company's portfolio and increasing the total capacity of renewable energy assets in the JLEN investment portfolio to 297.9MW.

The acquisition was funded by a draw-down on JLEN's revolving credit facility.

 

Richard Morse, Chairman of JLEN, said:

 

"We are pleased with JLEN's latest investment, which presents a diversification within the anaerobic digestion sector. This acquisition of a food waste fed AD plant in London, bridges two sub sectors of JLEN's existing portfolio, leveraging experience of the agricultural AD assets and the waste processing assets. The production of biogas to inject into the national grid and also to power its own fleet of collection vehicles, underlines the importance that assets such as these play in the UK's ambition to decarbonise its energy supply. We also value the opportunity to continue to work with the existing private shareholder to drive further value in the investment in future years."

For further information, please contact: 

Foresight Group

Chris Tanner

Chris Holmes

 

+44(0)20 3667 8100

Winterflood Investment Trusts 

Neil Langford

Chris Mills

+44(0)20 3100 0000

 

Newgate Communications

Elisabeth Cowell

Ian Silvera

 

+44(0)20 3757 6880

Praxis Fund Services

Matt Falla

 

+44(0)1481 755530

About JLEN

JLEN's investment policy is to invest in environmental infrastructure projects that have the benefit of long-term, predictable, wholly or partially inflation-linked cash flows supported by long-term contracts or stable regulatory frameworks.

Environmental Infrastructure is defined by the Company as infrastructure projects that utilise natural or waste resources or support more environmentally-friendly approaches to economic activity. This could involve the generation of renewable energy (including solar, wind, hydropower and biomass technologies), the supply and treatment of water, the treatment and processing of waste, and projects that promote energy efficiency.

JLEN's aim is to provide investors with an annual dividend that is sustainable and increases in line with inflation. The target dividend for the year to 31 March 2020 is 6.66 pence per share. The dividend is payable quarterly.

Further details of the Company can be found on its website www.jlen.com

 LEI: 213800JWJN54TFBMBI68

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQLIFLRFILVLIA
Date   Source Headline
23rd Mar 20217:00 amRNSAcquisition
8th Mar 202111:22 amRNSResult of EGM
3rd Mar 20217:00 amRNSAcquisition
24th Feb 20217:00 amRNSNotice of Capital Markets Day
16th Feb 202112:28 pmRNSUpdate research from QuotedData
16th Feb 20217:00 amRNSPublication of Shareholder Circular, Notice of EGM
15th Feb 202110:09 amRNSDirector Declaration
12th Feb 20217:00 amRNSNet Asset Value and Dividend Declaration
4th Feb 20217:00 amRNSAcquisition
4th Dec 20201:17 pmRNSAcquisition
26th Nov 20207:00 amRNSHalf-year Results, Dividend Declaration
27th Oct 20207:00 amRNSNotice of Results
18th Sep 20207:00 amRNSAcquisition
15th Sep 20206:00 pmRNSHolding(s) in Company
3rd Sep 20202:22 pmRNSResult of AGM and Directorate Change
18th Aug 20207:00 amRNSNet Asset Value and Dividend Declaration
7th Aug 20204:38 pmRNSDirector Declaration
30th Jun 20205:12 pmRNSNotice of AGM
11th Jun 20204:25 pmRNSDirectorate Change
11th Jun 20207:00 amRNSAnnual Financial Report
28th May 20207:00 amRNSNet Asset Value and Dividend
14th May 202011:16 amRNSUpdate research from QuotedData
7th May 20207:00 amRNSNotice of Results
2nd Apr 20207:00 amRNSAcquisition
1st Apr 20208:06 amRNSTotal Voting Rights
26th Mar 20207:00 amRNSCOVID-19 Update
5th Mar 20202:11 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSAppointment of Non-Executive Director
27th Feb 20207:00 amRNSResult of Placing
13th Feb 20209:33 amRNSHolding(s) in Company
11th Feb 20207:02 amRNSRestructuring of Investment Advisory Arrangements
11th Feb 20207:00 amRNSProposed Placing
29th Jan 20207:00 amRNSNet Asset Value and Dividend Declaration
28th Jan 20207:00 amRNSPartnership Commitment
13th Dec 20197:00 amRNSAcquisition
4th Dec 20195:44 pmRNSHolding(s) in Company
21st Nov 20197:00 amRNSHalf-year Results, Dividend Declaration
17th Oct 20197:00 amRNSNotice of Results
10th Sep 20197:45 amRNSUpdate research from QuotedData
29th Aug 20192:36 pmRNSHolding(s) in Company
29th Aug 20197:00 amRNSAcquisition
15th Aug 20197:00 amRNSNet Asset Value and Dividend Declaration
14th Aug 20194:22 pmRNSResult of AGM & Change of Company Name
19th Jul 20197:00 amRNSAcquisition
5th Jul 20195:05 pmRNSNotice of AGM
1st Jul 20192:51 pmRNSChange of Adviser
13th Jun 20197:00 amRNSAnnual Financial Report
5th Jun 20197:00 amRNSProposed Change of Investment Adviser
30th May 20197:00 amRNSNet Asset Value and Dividend Declaration
20th May 20197:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.